New formulation of an old drug in hypertension treatment: the sustained release of captopril from cyclodextrin nanoparticles

References

• LiebauGCaptopril in congestive heart failureKlinische Wochenschrift1982601071136210798
   PubMedGoogle Scholar
• ChengWTWangSLLinSYSolid-state interaction study on the captopril/lubricants systems accelerated by grinding processJ Phys Chem Sol20086910071016
   Web of Science ®Google Scholar
• NurAOZhangJSCaptopril floating and/or bioadhesive tablets: design and release kineticsDrug Dev Ind Pharm20002696596910914320
   PubMed Web of Science ®Google Scholar
• KhanMASastrySVVaithiyalingamSRCaptopril gastrointestinal therapeutic system coated with cellulose acetate pseudolatex: evaluation of main effects of several formulations variablesInt J Pharm200019314715610606777
   PubMed Web of Science ®Google Scholar
• Jiménez-MartínezbIQuirino-BarredaTVillafuerte-RoblesLSustained delivery of captopril from floating matrix tabletsInt J Pharm2008362374318588962
   PubMed Web of Science ®Google Scholar
• NurAOZhangJSRecent progress in sustained/controlled oral delivery of captopril: an overviewInt J Pharm2000b19413914610692638
   PubMed Web of Science ®Google Scholar
• LoftssonTDuchêneDCyclodextrins and their pharmaceutical applicationsInt J Pharm200732911117137734
   PubMed Web of Science ®Google Scholar
• TanakaTAzevedoMBMDuranNColorectal cancer chemo-prevention by 2 β-cyclodextrin inclusion compounds of auraptene and 4′-geranyloxyferulic acidInter J Cancer2010126830840
   PubMed Web of Science ®Google Scholar
• MeissnerYLamprechtAAlternative drug delivery approaches for the therapy of inflammatory bowel diseaseJ Pharm Sci2008972878289117948914
   PubMed Web of Science ®Google Scholar
• DavisMEBrewsterMECyclodextrin-based pharmaceutics: past, present and futureNat Rev Drug Discovery2004310231035
   PubMed Web of Science ®Google Scholar
• De AzevedoMBMAldereteJBLinoACSBiological activities of violacein, a new antitumoral indol derivative, in an inclusion complex with β-cyclodextrinJ Inclusion Phenom Macrocyclic Chem20003793101
   Web of Science ®Google Scholar
• CorrêaDHMeloPSde CarvalhoCADehydrocrotonin and its beta-cyclodextrin complex: cytotoxicity in V79 fibroblasts and rat cultured hepatocytesEur J Pharmacol2005510172415740720
   PubMed Web of Science ®Google Scholar
• MeloPSJustoGZde AzevedoMBMViolacein and its β-cyclodextrin complexes induce apoptosis and differentiation in HL60 cellsToxicology200318621722512628314
   PubMed Web of Science ®Google Scholar
• HirayamaFUekamaKCyclodextrin-based controlled drug release systemAdv Drug Deliv Rev19993612514110837712
   PubMed Web of Science ®Google Scholar
• KeipertSFedderJBöhmAHankeBInteractions between cyclodextrins and pilocarpine: as an example of hydrophilic drugInt J Pharm1996142153162
   Web of Science ®Google Scholar
• VyasASarafSSarafSCyclodextrin based novel drug delivery systemsJ Inclusion Phenom Macrocyclic Chem2008622342
   Web of Science ®Google Scholar
• IkedaYKimuraKHirayamaFControlled release of a water-soluble drug, captopril, by a combination of hydrophilic and hydrophobic derivativesJ Control Release20006627128010742586
   PubMed Web of Science ®Google Scholar
• IkedaYMotouneSMatsuokaTInclusion complex formation of captopril with α- and β-cyclodextrins in aqueous solution: NMR spectroscopic and molecular dynamic studiesJ Pharm Sci2002912390239812379924
   PubMed Web of Science ®Google Scholar
• SantosRASCampagnole-SantosMJPinheiroSVBFerreiraAJThe renin-angiotensin system: emerging conceptsCurr Hypertens Rev20062219226
   Google Scholar
• CruzJRBeckerBAMorrisKFLariveCKNMR characterization of the host-guest inclusion complex between beta-cyclodextrin and doxepinMagn Reson Chem20084683884518615634
   PubMed Web of Science ®Google Scholar
• MeierMMLuizMTBFarmerPJSzpoganiczBThe influence of β- and γ-cyclodextrin cavity size on the association constant with decanoate and octanoate anionsJ Inclusion Phenom Macrocyclic Chem200140291295
   Web of Science ®Google Scholar
• SchneiderH-JHacketFRüdigerVIkedaHNMR studies of cyclodextrins and cyclodextrin complexesChem Rev1998981755178611848948
   PubMed Web of Science ®Google Scholar
• CalderiniAPessineFBTSynthesis and characterization of inclusion complex of the vasodilatador drug minoxidil with β-cyclodextrinJ Incusion Phenom Macrocyclic Chem200860369377
   Web of Science ®Google Scholar
• RymdémRCarlforsJStilbsPSubstrate binding to cyclodextrins in aqueous solution: a multicomponent self diffusion studyJ Inclusion Phenom Macrocyclic Chem19831159168
   Google Scholar
• LinMJayawickramaDARoseRANuclear magnetic resonance spectroscopic analysis of the selective complexation of the cis and trans isomers of phenylalanylproline by β-cyclodextrinAnal Chim Acta1995307449457
   Web of Science ®Google Scholar
• HassanMSuleimanMNajibNImprovement of the in vitro dissolution characteristics of famotidine by inclusion in β-cyclodextrinInt J Pharm1990581924
   Web of Science ®Google Scholar
• Perdomo-LópezIRodríguez-PérezAIYzquierdo-PeiroJMEffect of cyclodextrins on the solubility and antimycotic activity of sertaconazole: experimental and computacional studiesJ Pharm Sci2002912408241512379926
   PubMed Web of Science ®Google Scholar
• Cabral MarquesHHadgraftJKllawayIStudies of cyclodextrin inclusion complexes I The salbutamol-cyclodextrin complex as studied by phase solubility and DSCInt J Pharm199063259266
   Web of Science ®Google Scholar
• Esclusa-DiazMTorres-LabandeiraJKataMVila-JatoJInclusion complexation of glibenclamide with 2-hydroxypropyl-b-cyclodextrin in solution and in solid stateEur J Pharm Sci19941291296
   Web of Science ®Google Scholar
• FigueirasARibeiroLTorres-LabandeiraJVeigaFJBEvaluation of host-guest complex formation between a benzimidazolic derivative and cyclodextrins by UV-VIS spectrophotometry and differential scaning calorimetryJ Inclusion Phenom Macrocyclic Chem200757531535
   Web of Science ®Google Scholar